TrialReader


Alert Burden When Monitoring Patients at Home

NCT07096648 — Active not recruiting, 110 participants, Bispebjerg Hospital

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  
RegistryNCT07096648, acronym WARD-HOME I
StatusActive not recruiting
Study typeObservational
Enrollment110 (Actual)
SponsorBispebjerg Hospital (Other)
ConditionsContinuous Monitoring, Vital Signs Monitoring, Hospital at Home, Remote Monitoring
InterventionsContinuous vital sign monitoring (Device)
Datesstart 2025-06-16, primary completion 2025-09-01 (estimated), completion 2025-12-01 (estimated), first posted 2025-07-31, last updated 2025-07-31
Locations1 site in Denmark

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Continuous Monitoring All trials for Vital Signs Monitoring All trials of Continuous vital sign monitoring

-Summary

The aim of this observational study is to evaluate the burden and clinical relevance of vital sign alerts during home monitoring in recently discharged medical patients.

The primary outcome is the total number of vital sign alerts per patient per day. Secondary outcomes include the number of alerts per specific vital sign parameter, the frequency of alerts during daytime versus evening and nighttime, and the peak alert time during the day.

We will compare alert data without filtering to data processed with AI-driven filtering methods to assess if these filters reduce the number of non-actionable alerts while maintaining clinical relevance.

Participants will be equipped with wearable devices to continuously monitor heart rate, respiratory rate, blood pressure, and oxygen saturation during the first days after hospital discharge. Vital signs will be transmitted remotely, and alerts will be generated based on predefined thresholds.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
PatientsDevice: Continuous vital sign monitoringPatients discharged from hospital after admission due to an acute medical condition
  • Continuous vital sign monitoring (Device): Continuous monitoring of vital signs performed using up to three CE- and FDA approved devices measuring heart rate, respiratory rate, systolic- and diastolic blood pressure, and SpO2. Data is transmitted to a CE-approved smartphone application that generates alerts in response to deviations based on predefined thresholds for duration and severity.

+Outcome measures

Primary outcomes

  • Number of vital sign alerts per patient per day [Up to 8 days]

Secondary outcomes

  • Number of alerts per specific vital sign parameter per patient per 24-hour period [Up to 8 days]
  • Frequency of any vital sign alert per hour analyzed as daytime (08.00-15.59) vs. evening and nighttime (16.00-07.59) [Up to 8 days]
  • The hour of day with highest frequency of alerts [up to 8 days]

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

* Adult patients (≥18 years) admitted with an acute medical disease and scheduled for discharge within five days from inclusion.

Exclusion Criteria:

* Allergy to plaster/silicone, pacemaker or ICD, inability to give informed consent or deemed not able to open the front door when visited by the investigator.

+Locations (1)

FacilityCityCountryStatus
Bispebjerg HospitalCopenhagenDenmark

+Investigators

My Notes